Members

Investor Relations Update May 20, 2025

We are pleased to provide the following updates on recent developments and financial matters.

Financial and Governance Updates:

On May 19, 2025, the MediXall Group Inc 10-Q for the first quarter of 2024 was filed with the U.S. Securities and Exchange Commission. You can access and review this 10-Q by going to the Investor Update under the Investor Relations tab at https://www.healthkarmagroup.com/ .

Below are 2 significant excerpts from this filing:

During 2023, the Company underwent a nearly complete change in the Board of Directors and management resulting in a substantial transformation of the Company’s focus, product offerings, and channel emphasis. This shift has led to significant financial growth, with revenue of $118,142 in the first quarter of 2024 surpassing that of the same period in 2023 of $77,866, an increase of 52% and exceeded the total revenue for the entire year of 2022 by almost 100%. 

Moreover, the Company successfully reduced its net loss in the first three months of2024 by $734,895 from the same period in 2023. The net loss for the three monthsended March 31, 2024, was $486,600 versus $1,221,495 for the same period in 2023.This is the result of the new management taking decisive steps to reduce costs bymoving its corporate office, continuing the remote work strategy started under pandemicconditions, dramatically reducing the number of employees by procuring out-sourcedmarketing expertise, its User Experience/User Interface (UX/UI) platform, its ITdevelopment and maintenance, and the use of independent sales consultants and brokers.

Our team is working diligently with our auditors and anticipate the remaining 2024 10-Q reportswill be filed shortly. We appreciate your patience and understanding as we prioritize accuracyand compliance in this process.

Closing Remarks:

‍We remain steadfast in our focus on driving growth, fostering innovation, and delivering value to our stakeholders. Thank you for your continued support and confidence in our mission.

For further inquiries, please contact us via:
• Email: IR@healthkarmagroup.com
• Voice Message: (954) 737-3435
• Investor Relations Tab: https://www.healthkarmagroup.com/

Yours in health and progress,

Health Karma Investor Relations